Biochemistry alum (BS’18) Angelica Lackey recently attended the 6th Global Symposium on Ketogenic Therapies for Neurological Disorders in Jeju, Korea. There she learned about the “individualization of ketogenic therapies (leaning toward personalized medicine), the gut-brain-microbiome relationship and influence on diet efficacy/seizure control, use of the diet for status epilepticus (a dangerous condition in which someone seizes continuously without recovering consciousness), and evidence proposing indications for the diet in other neurological disorders (largely solid tumors and autism).”

She was inspired by “the eager and gracious collaboration between diet centers and amongst countries; also the enthusiasm for basic, translation, and clinical research and application of ketogenic therapies for refractory disease types and as adjuvant therapy to enhance efficacy and overall standard of care was invigorating and inspirational (to say the least)”

Angelica adds that she will continue to pursue this field and believes that her success “thus far largely stems from the education and support I received from SU. She adds that her success can speak to the potential of SU SOS’s Capstone experience and independent research projects.”